Kwang Dong made registration of patent with Kyungokko in Japan for prevention and treatment of male infertility

Published: 2017-03-23 13:23:37

Updated: 2017-03-23 13:23:37

Kwang Dong Pharmaceutical(CEO Sung-Won Choi) announced on the 21^st that Kyungokko KwangDong, which has been exported to Japan, registered a patent(No. JP6063499, expiring on Feb 27 2035) at the Japan Patent Office as it was studied to have efficacy in prevention and treatment of male infertility.

Kyungokko KwangDong, a product exported by Kwang Dong Pharmaceutical to Japan, herbal tonic to rec...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.